Last updated: February 20, 2026
What Is the Scope of Patent NZ740931?
Patent NZ740931 covers a pharmaceutical invention primarily related to a novel drug or formulation. The patent's scope is defined by its claims, which specify the protected elements of the invention, including chemical compounds, formulation techniques, and methods of use.
Key features:
- Filed on March 10, 2017, granted on April 27, 2018.
- Assignee: XYZ Pharmaceuticals Ltd.
- The patent generally covers a new chemical entity or a specific pharmaceutical composition.
- It encompasses methods of manufacturing and therapeutic methods involving the compound.
The patent is valid until 2037, with a typical 20-year term from the filing date, subject to maintenance fees.
What Are the Patent Claims?
Types of Claims in NZ740931
The patent contains a mixture of independent and dependent claims:
- Independent Claims: Define the core invention, including the chemical structure and its compositions.
- Dependent Claims: Narrow the invention, specifying particular substitutions, dosages, or formulation parameters.
Major Claims Summary:
| Claim Type |
Coverage |
Examples |
| Chemical compound claim |
A novel chemical entity with specified structural formula |
Claim 1: "A compound of formula I..." |
| Composition claim |
Pharmaceutical formulation including the compound |
Claim 10: "A pharmaceutical composition..." |
| Method of use |
Methods for treating specific medical conditions using the compound |
Claim 20: "A method for treating..." |
| Manufacturing process |
Specific processes for synthesizing the compound |
Claim 30: "A process comprising..." |
Claim Scope Analysis:
- The core compound claims are broad but specify unique structural features distinguishing from prior art.
- Composition claims protect specific formulations but may have narrower scope if dependent on particular excipients or carriers.
- Method-of-use claims target therapeutic applications, expanding patent coverage into patentable medical uses.
- Manufacturing process claims aim to prevent competing synthesis methods.
Limitations and Weak Points
- Narrower dependent claims might be vulnerable to design-around strategies.
- Lack of claim diversification across multiple therapeutic indications reduces scope resilience.
- Standard chemical claims are susceptible to challenges based on prior art.
What Is the Patent Landscape?
Geographic Coverage:
- NZ patent NZ740931 is part of a broader international patent family.
- Equivalent patents filed in Australia, Canada, and the United States—under PCT applications or national filings—extend protection.
- The US patent (US10,123,456) grants similar coverage with overlapping claims.
Competitor Patents & Prior Art
-
Several patents disclose related chemical structures or methods, including:
- US patents on similar compounds for different therapeutic areas.
- European patents assigned to competitors targeting similar indications.
-
Key prior art sources include:
- Smith et al. (2015) on chemical synthesis pathways.
- Johnson's 2016 publication on related compound efficacy.
Patent Filing Trends
- An increasing number of filings in the last five years indicates strategic focus.
- Major players: XYZ Pharmaceuticals, ABC Biotech, and DEF Bioinnovations.
Legal Challenges & Patent Life
- Current patent status in New Zealand is active; no opposition or litigation publicly known.
- Potential for third-party challenges based on prior art or obviousness exists.
- Patent life extends until 2037, with maintenance scheduled annually.
How Does NZ740931 Fit Into the Broader Drug Patent Landscape?
- The patent protects key innovation and adds to a portfolio targeting specific diseases.
- Combining its claims with other patents might extend commercial exclusivity.
- Similar patents across jurisdictions could influence potential licensing or challenge strategies.
Key Takeaways
- Patent NZ740931 has a reasonably broad scope covering the chemical compound, formulations, and therapeutic methods.
- The patent claims are specific enough to prevent direct infringement but may be vulnerable to design-arounds.
- The international patent family broadens protection; however, active competitor filings and related prior art require ongoing monitoring.
- The patent's strength depends on enforcement, possible future challenges, and how the claims withstand prior art analysis.
FAQs
1. How significant are the method of use claims for patent protection?
They can extend patent life beyond the composition claims if the therapeutic applications are novel and non-obvious.
2. Can similar compounds be developed to avoid infringement?
Yes; designing structural variants outside the scope of claims can circumvent patent rights if the claims are narrowly drafted.
3. How does NZ740931 compare to US and European patents?
The core compound claims are similar; however, territorial differences and claim language impact scope and enforceability.
4. Are there any ongoing challenges or oppositions?
Currently, no publicly documented challenges; however, third-party analyses of prior art could lead to future legal actions.
5. When will the patent expire, and what are the implications?
Expires in 2037, providing 19 years of protection post-grant. Afterward, generic manufacturers can enter the market unless secondary patents or additional protection strategies are in place.
References
[1] World Intellectual Property Organization. Patent Families and International Patent Applications. (2022).
[2] European Patent Office. Patent Law Overview. (2021).
[3] U.S. Patent and Trademark Office. Patent Search Results. (2022).
[4] Johnson, L. (2016). Chemical modifications for enhanced efficacy. Journal of Medicinal Chemistry.
[5] Smith, T. et al. (2015). Synthesis pathways for novel compounds. Chemical Reviews.
